Jenfer Biosciences Pvt. Ltd. is a growing pharmaceutical company offering PCD Pharma Franchise opportunities across India, with a diverse portfolio of pharmaceutical formulations covering multiple therapeutic segments. Based in Ambala Cantt, Haryana, the company is engaged in the manufacturing and supply of DCGI-approved pharmaceutical products, including tablets, capsules, injections, oral liquids, dry powders, ointments, eye and ear drops, and Ayurvedic formulations.

For the Oncology PCD Pharma Franchise Companies category, Jenfer Biosciences can be positioned around its broad pharmaceutical portfolio and specialized formulation capabilities. Its product range includes medicines and formulations spanning anti-infectives, cardiovascular care, gastroenterology, hormones, neurology, nutritional supplements, gynecology, and other therapeutic areas. The company's listed portfolio also includes injectable formulations, which are an important part of hospital and specialty-care pharmaceutical supply.

Jenfer Biosciences provides monopoly-based franchise and distribution rights in selected vacant areas, along with product supply and business support for franchise associates. The company emphasizes quality, competitive pricing, timely order fulfillment, and customer satisfaction. Its manufacturing collaborations follow WHO-GMP and ISO quality norms, while its quality management system covers manufacturing through distribution and product documentation.

With a broad product portfolio, experienced professionals, and a nationwide franchise approach, Jenfer Biosciences continues to build its presence in India's pharmaceutical market and offers business opportunities for pharma professionals seeking reliable product and distribution support.